24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Non-Hodgkin’s Lymphoma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:28
Full list of Israeli startup M&As in 2025
17:24
Fintech unicorn Tipalti acquires Statement to expand real-time cash flow management
15:02
Full list of Israeli high-tech funding rounds in 2025
15:00
Coralogix raises $115 million Series E at over $1 billion valuation
More stories
Buzz
Most popular
Daily
Weekly
1
“We made another investment the morning after the war with Iran began”
2
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
3
Cyberattacks against Israel surge 700% in two days, says Radware
4
Google’s $32 billion acquisition of Wiz draws antitrust attention
5
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
More news
Non-Hodgkin’s Lymphoma
1 stories about Non-Hodgkin’s Lymphoma
Teva, Celltrion Gain FDA Approval for Generic Blood Cancer Bio-Drug
29.11.18
|
Lilach Baumer
Called Truxima, the drug has been approved to treat several conditions of non-Hodgkin’s lymphoma
